.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Teva
Novartis
Daiichi Sankyo
Accenture
US Department of Justice
Farmers Insurance
Chinese Patent Office
Fish and Richardson

Generated: November 19, 2017

DrugPatentWatch Database Preview

Rubicon Res Pvt Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for RUBICON RES PVT LTD, and what generic and branded alternatives to RUBICON RES PVT LTD drugs are available?

RUBICON RES PVT LTD has three approved drugs.

There is one tentative approval on RUBICON RES PVT LTD drugs.

Summary for Rubicon Res Pvt Ltd

US Patents:0
Tradenames:3
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rubicon Res Pvt Ltd
METOPROLOL TARTRATE
metoprolol tartrate
TABLET;ORAL200981-001Oct 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL208170-002May 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
METOPROLOL TARTRATE
metoprolol tartrate
TABLET;ORAL200981-003Oct 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
SILDENAFIL CITRATE
sildenafil citrate
TABLET;ORAL204883-001Jun 20, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL208170-003May 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL208170-001May 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
METOPROLOL TARTRATE
metoprolol tartrate
TABLET;ORAL200981-002Oct 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
Healthtrust
Medtronic
Harvard Business School
Mallinckrodt
Fuji
Merck
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot